Predictors of portal vein thrombosis after splenectomy in patients with cirrhosis

doi:10.4254/wjh.v16.i2.241

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1374)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-2) series.

Item

Count

PDF

WORD

HTML

587

Figures (1-3)

113

Tables (1-2)

108

Sum=864

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

103

Download

376

Sum=479

Feb 27, 2024 (publication date) through Jul 23, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Hepatol. Feb 27, 2024; 16(2): 241-250
Published online Feb 27, 2024. doi: 10.4254/wjh.v16.i2.241

Full Size Figure Download Figure

Figure 3 Time-dependent curve analysis. A: Cumulative incidence of portal vein thrombosis in the groups with monthsdel‎ end-stage liver disease score ≤ 10 and > 10 was significantly different (P < 0.05); B: Cumulative incidence of PVT in patients with portal vein diameter (PVD) < 14.5 mm and PVD ≥ 14.5 mm group was significantly different (P < 0.05). PVT: Portal vein thrombosis; MELD: Monthsdel‎ end-stage liver disease.

Citation: Li T, Wang LL, Li YP, Gan J, Wei XS, Mao XR, Li JF. Predictors of portal vein thrombosis after splenectomy in patients with cirrhosis. World J Hepatol 2024; 16(2): 241-250
URL: https://www.wjgnet.com/1948-5182/full/v16/i2/241.htm
DOI: https://dx.doi.org/10.4254/wjh.v16.i2.241